Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Udai S. Kammula
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Adoptively Transferred Tumor-Infiltrating T Cells Target Somatic Cancer Mutations in a Human Papillomavirus+ Cancer Patient With Complete Tumor Regression
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Human Papillomavirus and Cervical Cancer
Emerging Infectious Diseases
Epidemiology
Infectious Diseases
Microbiology
Isolation and Characterization of Human Papillomavirus Type 6-Specific T Cells Infiltrating Genital Warts.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Post-Treatment Human Papillomavirus Antibody Kinetics in Cervical Cancer Patients
Philosophical Transactions of the Royal Society B: Biological Sciences
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Durable Complete Response From Metastatic Melanoma After Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
Cancer immunology research
Cancer Research
Immunology
Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia
Obstetrics and Gynecology
Gynecology
Obstetrics
Human Papillomavirus Infection After Treatment for High-Grade Cervical Intraepithelial Neoplasia
Biotechnology and Biotechnological Equipment
Biotechnology
Cervical Cancer, Human Papillomavirus, and Vaccination
BMJ